Atlas Trials

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer

Clinical trial NCT03281681 · WITHDRAWN

Trial details

NCT number
NCT03281681
Sponsor
DelMar Pharmaceuticals, Inc.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-03-01
Primary completion
2022-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.